TNF and inflammatory bowel disease: The treatment of IBD patients with TNF-α monoclonal antibody (such as infliximab and golomumab) could effectively alleviate the disease (Rutgeerts et al., 2005; Sandborn et al., 2014; Iwanczak et al., 2017).